Bauer RJ - Search Results

1

Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane.

Carroll SF, Bernhard SL, Goff DA, Bauer RJ, Leach W, Kung AH. Carroll SF, et al. Among authors: bauer rj. Bioconjug Chem. 1994 May-Jun;5(3):248-56. doi: 10.1021/bc00027a010. Bioconjug Chem. 1994. PMID: 7918744

2

Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique properties.

Better M, Bernhard SL, Fishwild DM, Nolan PA, Bauer RJ, Kung AH, Carroll SF. Better M, et al. Among authors: bauer rj. J Biol Chem. 1994 Apr 1;269(13):9644-50. J Biol Chem. 1994. PMID: 8144553 Free article.

3

T cell-targeted immunofusion proteins from Escherichia coli.

Better M, Bernhard SL, Williams RE, Leigh SD, Bauer RJ, Kung AH, Carroll SF, Fishwild DM. Better M, et al. Among authors: bauer rj. J Biol Chem. 1995 Jun 23;270(25):14951-7. doi: 10.1074/jbc.270.25.14951. J Biol Chem. 1995. PMID: 7541032 Free article.

4

Biochemical characterization of recombinant fusions of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein. Implications in biological activity.

Abrahamson SL, Wu HM, Williams RE, Der K, Ottah N, Little R, Gazzano-Santoro H, Theofan G, Bauer R, Leigh S, Orme A, Horwitz AH, Carroll SF, Dedrick RL. Abrahamson SL, et al. J Biol Chem. 1997 Jan 24;272(4):2149-55. doi: 10.1074/jbc.272.4.2149. J Biol Chem. 1997. PMID: 8999916 Free article.

5

Alteration of the pharmacokinetics of small proteins by iodination.

Bauer RJ, Leigh SD, Birr CA, Bernhard SL, Fang M, Der K, Ihejeto NO, Carroll SF, Kung AH. Bauer RJ, et al. Biopharm Drug Dispos. 1996 Dec;17(9):761-74. doi: 10.1002/(SICI)1099-081X(199612)17:9<761::AID-BDD992>3.0.CO;2-Z. Biopharm Drug Dispos. 1996. PMID: 8968529

6

A phase I safety and pharmacokinetic study of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in healthy male volunteers.

Bauer RJ, White ML, Wedel N, Nelson BJ, Friedmann N, Cohen A, Hustinx WN, Kung AH. Bauer RJ, et al. Shock. 1996 Feb;5(2):91-6. doi: 10.1097/00024382-199602000-00002. Shock. 1996. PMID: 8705395 Clinical Trial.

7

The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats.

Bauer RJ, Der K, Ottah-Ihejeto N, Barrientos J, Kung AH. Bauer RJ, et al. Pharm Res. 1997 Feb;14(2):224-9. doi: 10.1023/a:1012013113759. Pharm Res. 1997. PMID: 9090714

8

Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteers.

Bauer RJ, Wedel N, Havrilla N, White M, Cohen A, Carroll SF. Bauer RJ, et al. J Clin Pharmacol. 1999 Nov;39(11):1169-76. J Clin Pharmacol. 1999. PMID: 10579148 Clinical Trial.

9

Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI21) after liver surgery in rats and humans.

Wiezer MJ, Langendoen SI, Meijer C, Bauer RJ, White ML, Carroll SF, Meyer S, Thijs LG, van Leeuwen PA. Wiezer MJ, et al. Among authors: bauer rj. Shock. 1998 Sep;10(3):161-6; discussion 167-8. doi: 10.1097/00024382-199809000-00002. Shock. 1998. PMID: 9744643 Clinical Trial.

10

In vitro and in vivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion molecule.

Ammons WS, Bauer RJ, Horwitz AH, Chen ZJ, Bautista E, Ruan HH, Abramova M, Scott KR, Dedrick RL. Ammons WS, et al. Among authors: bauer rj. Neoplasia. 2003 Mar-Apr;5(2):146-54. doi: 10.1016/s1476-5586(03)80006-4. Neoplasia. 2003. PMID: 12659687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters